Profil
Guy Debruyne is currently a Director at Le Bocholtz SA, Mithra Pharmaceuticals CDMO SA, Blue Star Invest SA, and a Director at CG Cube SA. He was previously a Non-Executive Director at Mithra Pharmaceuticals SA.
Postes actifs de Guy Debruyne
| Sociétés | Poste | Début |
|---|---|---|
| Blue Star Invest SA | Chief Executive Officer | - |
| CG Cube SA | Director/Board Member | - |
| Le Bocholtz SA | Director/Board Member | - |
Mithra Pharmaceuticals CDMO SA
 Mithra Pharmaceuticals CDMO SA Pharmaceuticals: MajorHealth Technology Part of Mithra Pharmaceuticals SA, Mithra Pharmaceuticals CDMO SA is a Belgian biotech company that focuses on transforming women's health through innovation. The private company is based in Liege, Belgium and has a global presence in over 100 countries with a staff count of approximately 300. Mithra CDMO is an integrated research, development, and manufacturing platform that takes products from proof of concept to market. The company's current research and development pipeline includes two products based on the novel natural estrogen, estetrol (e4), as well as three complex therapeutics. The company was founded in 2013, and the CEO is François Fornieri. | Director/Board Member | - |
Anciens postes connus de Guy Debruyne
| Sociétés | Poste | Fin |
|---|---|---|
| MITHRA PHARMACEUTICALS S.A. | Director/Board Member | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MITHRA PHARMACEUTICALS S.A. | Health Technology |
| Entreprise privées | 4 |
|---|---|
| Le Bocholtz SA | |
Mithra Pharmaceuticals CDMO SA
Mithra Pharmaceuticals CDMO SA Pharmaceuticals: MajorHealth Technology Part of Mithra Pharmaceuticals SA, Mithra Pharmaceuticals CDMO SA is a Belgian biotech company that focuses on transforming women's health through innovation. The private company is based in Liege, Belgium and has a global presence in over 100 countries with a staff count of approximately 300. Mithra CDMO is an integrated research, development, and manufacturing platform that takes products from proof of concept to market. The company's current research and development pipeline includes two products based on the novel natural estrogen, estetrol (e4), as well as three complex therapeutics. The company was founded in 2013, and the CEO is François Fornieri. | Health Technology |
| Blue Star Invest SA | |
| CG Cube SA |
